Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith

摘要

The invention relates to at least one pyrrolotriazine derivative, at least one pharmaceutical composition comprising at least one pyrrolotriazine derivative, and at least one method of using at least one pyrrolotriazine derivative to treat at least one kinase-associated condition